Target volume delineation and patterns of recurrence in the modern era
JG Bazan, AJ Khan - Seminars in Radiation Oncology, 2022 - Elsevier
Delineation of treatment targets and organs-at-risk (OAR) for treatment planning is the
standard of care across all disease sites for curative radiation therapy. However, this …
standard of care across all disease sites for curative radiation therapy. However, this …
[HTML][HTML] PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases
L Beaton, L Nica, S Tyldesley, K Sek, G Ayre… - Radiation …, 2020 - Springer
Abstract Background To validate the Radiation Therapy Oncology Group (RTOG) and
European Society for Radiotherapy and Oncology (ESTRO) breast cancer nodal clinical …
European Society for Radiotherapy and Oncology (ESTRO) breast cancer nodal clinical …
Regional Lymph Node Radiation Is Not the Main Risk Factor for Breast Cancer Related Lymphedema: Stop Chasing Radiation Doses, Fractionation or Techniques …
GE Naoum, AG Taghian - International Journal of Radiation …, 2023 - redjournal.org
For patients with breast cancer with positive-lymph-nodes (LNs), the goal of axillary
management is to balance optimum tumor control through axillary surgery/regional …
management is to balance optimum tumor control through axillary surgery/regional …
[HTML][HTML] 乳腺癌术后放疗后复发的危险因素及复发模式
肖若敏， 陈子琴， 罗家顺， 吴涛 - Advances in Clinical Medicine, 2024 - hanspub.org
乳腺癌是目前威胁全球女性健康的第一大肿瘤, 据全球癌症统计显示, 2020 年全球新发癌症病例
1929 万例, 其中乳腺癌新增人数达约230 万例, 发病率首次超过了肺癌, 居恶性肿瘤首位 …
1929 万例, 其中乳腺癌新增人数达约230 万例, 发病率首次超过了肺癌, 居恶性肿瘤首位 …
Mapping of Level I Axillary Lymph Nodes in Patients with Newly Diagnosed Breast Cancer: Optimal Target Delineation and Treatment Techniques for Breast and …
XR Zhao, N Guo, C Ma, XN Yan, Y Tang, H Jing… - Practical Radiation …, 2022 - Elsevier
Purpose To map the locations of level I axilla (Ax-L1) lymph nodes (LNs), evaluate the
clinical target volume (CTV) coverage defined by the Radiation Therapy Oncology Group …
clinical target volume (CTV) coverage defined by the Radiation Therapy Oncology Group …